Köpfe

Cécile Ronckers

Dr. Ronckers
Titel:Dr.
Aktuelle Position:Wissenschaftliche Mitarbeiterin
Fachbereich:Biometrie und Registerforschung
Dienstadresse:

Institut für Biometrie und Registerforschung
Fehrbelliner Straße 38
16816 Neuruppin

Diensttelefon:+49 3391 39 14590
Dienst-E-Mail:cecile.ronckers@mhb-fontane.de
 
Curriculum Vitae

Dr. Cécile Ronckers hat einen Master-Abschluss in Gesundheitswissenschaften (Universität Maastricht, 1995) und einen PhD in Epidemiologie (Vrije Universiteit Amsterdam, 2001). Am U.S. National Cancer Institute erwarb sie Forschungserfahrung in Risikomodellierung, Strahlenwissenschaft, Krebsepidemiologie, und Studien zu Spätfolgen der Krebstherapie (1999-2006). Diese Studien setzte sie fort am Emma Kinderkrankenhaus/AMC in Amsterdam (Niederlande), eingebettet in das Niederländische LATER Konsortium. Ihr Forschungsprogramm über zweite Tumoren und Nebenwirkungen von Radiotherapie führt sie seit 2018 am neu gegründeten Princess Máxima Center for Pediatric Oncology in Utrecht (Niederlande). Sie ist ein aktives Mitglied der transatlantischen Konsortien PENTEC und IGHG zur Synthese und Translation wissenschaftlicher Evidenz in Empfehlungen für die Versorgung von Langzeitüberlebenden von Kinderkrebs sowie des Beirats des Europäischen PanCare Konsortiums. Dr. Ronckers ist seit 2019 an der Medizinischen Hochschule Brandenburg tätig als Projektkoordinator für ein Projekt über die Rolle und Bedeutung der Zweitmeinung im deutschen Gesundheitssystem aus Sicht von Patienten und Ärzten (ZWEIT), nd als Senior-Wissenschaftler im Institut für Biometrie und Registerforschung. Ihren vollständigen wissenschaftlichen Lebenslauf finden Sie hier.

Publikationen

Streefkerk N, Fioole LCE, Beijer JGM, Feijen ELAM, Teepen JC, Winther JF, Ronckers CM, Loonen JJ, van Dulmen-den Broeder E, Skinner R, Hudson MM, Tissing WJE, Korevaar JC, Mulder RL, Kremer LCM. Large variation in assessment and outcome definitions to describe the burden of long-term morbidity in childhood cancer survivors: A systematic review. Pediatr Blood Cancer. In press

Van der Kooi ALF, Mulder RL, Hudson MM, Kremer LCM, Skinner R, Constine LS, van Dorp W, van Dulmen-den Broeder E, Falck-Winther J, Wallace WH, Waugh J, Woodruff TK, Anderson RA, Armenian SH, Bloemenkamp KWM, Critchley HOD, Demoor-Goldschmidt C, Ehrhardt MJ, Green DM, Grobman WA, Iwahata Y, Krishna I, Laven JSE, Levitt G, Meacham LR, Miller ES, Mulders A, Polanco A, Ronckers CM, Samuel A, Walwyn T, Levine JM, van den Heuvel-Eibrink MM.Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. AM J Obstet. In press

Feijen EAM, Van Dalen EC, Van der Pal HJH, Reulen RC, Winter DL, Keuhni CE, Morsellino V, Alessi D, Allodji RS, Byrne J, Bardi E, Jakab Z, Grabow D, Garwicz S, Haddy N, Jankovic M, Kaatsch P, Levitt GA, Ronckers CM, Schindera C, Skinner R, Zalatel L, Hjorth L, Tissing WJE, De Vathaire F, Hawkins MM, Kremer LCM. Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study. Heart. In press.

Clement SC, Lebbink CA, Klein Hesselink MS, Teepen JC, Links TP, Ronckers CM, van Santen HM. Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study. Eur J Endocriol 2020; 183(2): 169-180.

Streefkerk N, Tissing WJE, Korevaar JC, van Dulmen-den Broeder E, Bresters D, van der Heiden-van der Loo M, van de Heuvel-Eibrink MM, Van Leeuwen FE, Loonen J, van der Pal HHJ, Ronckers CM, Versluys AB, de Vries ACH, Feijen EAM, Kremer LCM; Dutch LATER Study Group. A detailed insight in the high risks of hospitalizations in long-term childhood cancer survivors-A Dutch LATER linkage study. PLoS One 2020; 15(5): e0232708.

van Dijk M, van Leeuwen FE, Overbeek A, Lambalk CB, van den Heuvel-Eibrink MM, van Dorp W, Tissing WJ, Kremer LC, Loonen JJ, Versluys B, Bresters D, Ronckers CM, van der Pal HJ, Beerendonk CCM, Kaspers GJL, van Dulmen-den Broeder E, van den Berg MH. Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors: results of the DCOG LATER-VEVO study. J Cancer Res Clin Oncol 2020; 146(6): 1451-1462.

Streefkerk N, Tissing WJE, van der Heiden-van der Loo M, Lieke Feijen EAM, van Dulmen-den Broeder E, Loonen JJ, van der Pal HJH, Ronckers CM, van Santen HM, van den Berg MH, Mulder RL, Korevaar JC, Kremer LCM. The Dutch LATER physical outcomes set for self-reported data in survivors of childhood cancer. J Cancer Surviv 2020; 14(5): 666-676.

Nies M, Cantineau AEP, Arts EGJM, van den Berg MH, van Leeuwen FE, Muller Kobold AC, Klein Hesselink MS, Burgerhof JGM, Brouwers AH, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Horst-Schrivers ANA, Tissing WJE, Bocca G, van Dulmen-den Broeder E, Links TP. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma. Thyroid 2020; 30(8): 1169-1176.

Leerink JM, Feijen ELAM, van der Pal HJH, Kok WEM, Mavinkurve-Groothuis AMC, Kapusta L, Pinto YM, Maas AHEM, Bellersen L, Teske AJ, Ronckers CM, Louwerens M, van Dalen EC, van Dulmen-den Broeder E, Batenburg L, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, van Leeuwen FE, de Vries ACH, Weijers G, de Korte CL, Loonen JJ, Neggers SJCMM, Versluys ABB, Tissing WJE, Kremer LCM; LATER Study Group. Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study. Am Heart J 2020; 219: 89-98.

Verbruggen LC, Hudson MM, Bowers DC, Ronckers CM, Armstrong GT, Skinner R, Hoving EW, Janssens GO, van der Pal HJH, Kremer LCM, Mulder RL. Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors: A physician survey from the International Late Effects of Childhood Cancer Guideline Harmonization Group. J Neurooncol. 2020; 147(2): 417-425.

Leerink JM, Verkleij SJ, Feijen EAM, Mavinkurve-Groothuis AMC, Pourier MS, Ylänen K, Tissing WJE, Louwerens M, van den Heuvel MM, van Dulmen-den Broeder E, de Vries ACH, Ronckers CM, van der Pal HJH, Kapusta L, Loonen J, Bellersen L, Pinto YM, Kremer LCM, Kok WEM. Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review. Heart 2019; 105: 210-216.

Teepen JC, Ronckers CM, Kremer LCM. Colorectal Cancer Screening in Childhood Cancer Survivors. JNCI J Natl Cancer Inst 2019; 111: 1114-1115.

Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Jaspers MMW, van Santen HM, van der Heiden-van der Loo M, Janssens GO, Maduro JH, Bruggink AH, Jongmans MC, Kremer LCM, Ronckers CM, DCOG-LATER Study Group. Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer. Jama Oncol 2019; 5: 671-680.

Constine LS, Ronckers CM, Hua CH, Olch A, Kremer LCM, Jackson A, Bentzen SM. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. Clin Oncol 2019; 31: 199-207.

Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, Van den Heuvel-Eibrink MM, Van Dulmen-den Broeder E, Jaspers MMW, Van Santen HM, Van der Heiden-van der Loo M, Janssens GO, Maduro JH, Bruggink AH, Jongmans MC, Kremer LCM, Ronckers CM; DCOG-LATER Study Group. Histologically confirmed solid benign tumors among long-term childhood cancer survivors: A DCOG LATER record linkage study. JAMA Oncology 2019; 5(5): 671-680.

Teepen JC, Kremer LC, Van der Heiden-van der Loo M, Tissing WJ, Van der Pal HJ, Van den Heuvel-Eibrink MM, Loonen JJ, Louwerens M, Versluys B, Van Dulmen-den Broeder E, Visser O, Maduro JH, Van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort. Cancer Causes Control 2019; 30(9): 909-922.

Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bárdi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau EM, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Øfstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, De Vathaire F, Reulen RC. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. Eur J Cancer 2019; 117: 71-83.

Streefkerk N, Heins MJ, Teepen JC, Feijen EAM, Bresters D, Van Dulmen-den Broeder E, Van der Heiden-van der Loo M, Van den Heuvel-Eibrink MM, Van Leeuwen FE, Loonen JJ, Van der Pal HJH, Ronckers CM, Versluys AB, Tissing WJE, Korevaar JC, Kremer LCM; DCOG-LATER Study Group. The involvement of primary care physicians in care for childhood cancer survivors. Pediatr Blood Cancer 2019; 66(8): e27774.

Teepen JC, Kok JL, Kremer LC, Tissing WJE, Van den Heuvel M, Loonen JJ, Bresters D, Van der Pal HJ, Versluys AB, Van Dulmen den Broeder E, Nijsten T, Hauptmann M, Holllema N, Dolsma W, Van Leeuwen FE, Ronckers CM, for the DCOG LATER Study Group. Long-term risk of skin cancer among childhood cancer survivors: a DCOG-LATER cohort study. J Natl Cancer Inst 2019; 111(8): 845-853.

Kok JL*, Teepen JC*, Van Leeuwen FE, Tissing WJE, Neggers, SJCMM, Van der Pal HJ, Loonen JJ, Bresters D, Versluys AB, Van den Heuvel-Eibrink MM, Van Dulmen-den Broeder, Van der Heiden-van der Loo, Aleman BMP, Daniels L, Haasbeek CJA, Hoeben B, Janssens GO, Maduro JH, Oldenburger O, Van Rij C, Tersteeg RJHA, Hauptmann M, Kremer LCM, Ronckers CM, for the DCOGLATER Study Group. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age. Neuro Oncology 2019; 21(3): 392-403.

Vaarwerk B, Schoot RA, Maurice-Stam H, Slater O, Hartley B, Saeed P, Gajdosova E, Van den Brekel MW, Balm AJM, Hol MLF, Van Jaarsveld S, Kremer LCM, Ronckers CM, Mandeville HC, Pieters BR, Gaze MN, Davila Fajardo R, Strackee SD, Dunaway D, Smeele LE, Chisholm JC, Caron HN, Grootenhuis MA, Merks JHM. Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma. Pediatr Blood Cancer 2019; 66(2): e27498.

Wang Z, Balgobind BV, Virgolin M, Van Dijk IWEM, Wiersma J, Ronckers CM, Bosman PAN, Bel A, Alderliesten T. How do patient characteristics and anatomical features correlate to accuracy of organ dose reconstruction for Wilms' tumor radiation treatment plans when using a surrogate patient's CT scan? J Radiol Prot 2019; 39(2): 598-619.

Feijen EAM, Font-Gonzalez A, Van der Pal HJH, Kok WEM, Geskus RB, Ronckers CM, Bresters D, Van Dalen EC, Van Dulmen-den Broeder E, Van den Berg MH, Van der Heiden-van der Loo M, Van den Heuvel-Eibrink MM, Van Leeuwen FE, Loonen JJ, Neggers SJCMM, Versluys AB, Tissing WJE, Kremer LCM, on behalf of the DCOG LATER Study Group. Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER study. J Am Heart Assoc 2019; 8(1): e009122.

Van de Loo LEXM, Van den Berg MH, Overbeek A, Van Dijk M, Damen L, Lambalk CB, Ronckers CM, Van den Heuvel-Eibrink MM, Kremer LCM, Van der Pal HJ, Laven JSE, Tissing WJE, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, Van Leeuwen FE, Van Dulmenden Broeder E; DCOG LATER-VEVO Study Group. Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors. Fertil Steril 2019; 111(2): 372-380.

Meulepas J, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, Van Straten M, Klein MW, Merks JH, Visser O, van Leeuwen FE, Hauptmann M. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst 2019; 111: 256-263.

Grabow D, Kaiser M, Hjorth L, Byrne J, Ronckers CM, Kaatsch P. The PanCareSurFup cohort of 83,333 5-year survivors of childhood cancer - Methodology and results of harmonising data to establish a cohort from 12 European countries. Eur J Epidemiol 2018; 33(3): 335-349.

Van den Berg MH*, Overbeek A*, Lambalk CB, Kaspers GJL, Bresters D, Van den Heuvel-Eibrink MM, Kremer LC, Loonen JJ, Van der Pal HJ, Ronckers CM, Tissing WJE, Versluys AB, Van der Heiden-van der Loo M, Heijboer AC, Hauptmann M, Twisk JWR, Laven JSE, Beerendonk CCM, Van Leeuwen FE, Van Dulmen-den Broeder E; DCOG LATER-VEVO study group. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve. Hum Reprod 2018; 33(8): 1474-1488.

Virgolin M, Van Dijk IWM, Wiersma J, Ronckers CM, Witteveen C, Bel A, Alderliesten T, Bosman P. On the feasibility of automatically selecting similar patients in highly individualized radiotherapy dose reconstruction for historic data of paediatric cancer survivors. Med Phys 2018; 45(4): 1504-1517.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez MM, Van den Heuvel Eibrink MM, Kremer LCM, Gilbert ES, Van Leeuwen FE, Ronckers CM, Morton LM. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014. Leukemia 2018; 32(12): 2580-2589.

Teepen JC, Kok JL, Van Leeuwen FE, Tissing WJ, Dolsma WV, Van der Pal HJ, Van den Heuvel-Eibrink MM, HJ van der Pal, Loonen JJ, Bresters D, Versluys B, Van den Heuvel-Eibrink MM, Neggers SJCMM, Van Dulmen-den Broeder E, Van den Berg H, Van der Heiden-van der Loo M, Hauptmann M, Jongmans MC, Overbeek LI, Van de Vijver MJ, Kremer LCM, Ronckers CM and the DCOG LATER Study Group. Colorectal adenomas and cancers after childhood cancer treatment: a DCOG-LATER record linkage study. J Natl Cancer Inst 2018; 110(7): 758-767.

Haupt R, Essiaf S, Dellacasa C, Ronckers CM, Schrappe M, Hjorth L, Ladenstein R. PancareSurFup, ENCAA, ExPo-r-net Working Groups. The ‘Survivorship Passport’ for Childhood Cancer Survivors. Eur J Cancer 2018; 102: 69-81.

Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Byrne J, Feijen EAM, Fidler MM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuehni CE, Linge H, Øfstaas H, Ronckers CM, Skinner R, Teepen JC, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuonen R, Winther JF, De Vathaire F, Kremer LC, Hjorth L, Reulen RC; PanCareSurFup Consortium. Risk of soft-tissue sarcoma among 69,460 5-year survivors of childhood cancer in Europe. J Natl Cancer Inst 2018; 110(6): 649-660.

Wang Z, Van Dijk I, Wiersma J, Ronckers CM, Oldenburger F, Balgobind B, Bosman P, Bel A, Alderliesten T. Are age- and gendermatched childhood cancer patients' CT scans suitable for 2D-to-3D dose reconstruction. Med Phys 2018; 45(6): 2628-2638.

Chow EJ, Chen Y, Hudson MM, Feijen EAM, Kremer LC, Ronckers CM, Robison LL, Armstrong GT, Yasui Y. Prediction of ischemic heart disease and stroke among childhood cancer survivors. J Clin Oncol 2018; 36(1): 44-52.

Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, Byrne J, Feijen EAM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuonen R, Linge H, Maule M, Merletti F, Øfstaas H, Ronckers CM, Skinner R, Teepen J, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, De Vathaire F, Kremer LC, Hjorth L, Hawkins MM. Risk of subsequent primary bone cancers among 69,460 5-year survivors of childhood and adolescent cancer diagnosed throughout Europe. J Natl Cancer Inst 2018; 110(2).

Klein Hesselink M, Bocca G, Hummel Y, Brouwers A, Burgerhof J, Van Dam E, Gietema J, Havekes B, Van den Heuvel- Eibrink M, Corssmit E, Kremer L, Netea-Maier R, Van der Pal H, Peeters R, Plukker JTM, Ronckers CM, Santen HM, Van der Meer P, Links T, Tissing W. Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma. Thyroid 2017; 27: 1481-1489.

Teepen JC, Van Leeuwen FE, Tissing WJ, Van Dulmen-den Broeder E, Van den Heuvel-Eibrink MM, HJ van der Pal, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MW, Hauptmann M, Van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM. on behalf of the DCOG LATER Study Group. Long-term risk of subsequent malignant neoplasms after treatment for childhood cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. J Clin Oncol 2017; 35: 2288-2298.

Moskowitz Ch, Chou JF, Sklar CA, Barnea D, Ronckers CM, Novetsky Friedman D, Neglia JP, Turcotte L, Howell R, Henderon TO, Armstrong GT, Leisenring WM, Robison LL, Van Leeuwen FE, Pike M, Oeffinger K. Radiation-Associated Breast Cancer and Gonadal Hormone Exposure: A Report from the Childhood Cancer Survivor Study. Br J Cancer 2017; 117: 290-299.

Meulepas JM, Smets AM, Nievelstein RA, Gradowska P, Verbeke J, Holscher HC, Rutten MJ, Kieft M, Ronckers CM, Hauptmann M. Trends and patterns of computed tomography scan use among children in the Netherlands: 1990-2012. Eur Radiol 2017; 27: 2426-2433.

Nies M, Klein Hesselink MS, Huizinga GA, Sulkers S, Brouwers AH, Burgerhof JGM, Van Dam EWCM, Havekes B, Van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, Van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, Van Santen HM, Tissing WJE, Links TP, Bocca G. Long-term quality of life in adult survivors of pediatric differentiated thyroid carcinoma. J Clin Endocrinol Metabol 2016; 102: 1218-1226.

Klein Hesselink MS, Nies M, Bocca G, Brouwers AH, Burgerhof JG, Van Dam EW, Havekes B, Van den Heuvel-Eibrink MM, Corssmit EP, Kremer LC, Netea-Maier RT, Van der Pal HJ, Peeters RP, Schmid KW, Smit JW, Williams GR, Plukker JT, Ronckers CM, Van Santen HM, Tissing WJ, Links TP. Pediatric differentiated thyroid carcinoma in the Netherlands: a nationwide followup study. J Clin Endocrinol Metab 2016; 101: 2031-9.

Van Dijk IWEM, Van der Pal JHJ, Van Os RM, Roos YBWEM, Sieswerda E, Van Dalen EC, Ronckers CM, Oldenburger F, Van Leeuwen FE, Caron HN, Koning CCE, Kremer LCM. High risk of symptomatic stroke 25 years after radiotherapy for childhood cancer: a cohort analysis. Int J Radiat Oncol Biol Phys 2016; 96: 597-605.

Clement SC, Schoot RA, Slater O, Chisholm JC, Abela C, Balm AJM, Van den Brekel MW, Breunis WB, Chang YC, Davila Fajardo R, Dunaway D, Gajdosova E, Gaze MN, Gupta S, Hartley B, Kremer LCM, van Lennep M, Levitt GA, Mandeville HC, Pieters BR, Saeed P, Smeele LE, Strackee SD, Ronckers CM, Caron HN, Van Santen HM, Merks JHM. Endocrine disorders among survivors of childhood head and neck rhabdomyosarcoma. Eur J Cancer 2016; 54: 1-10.

Meulepas JM, Ronckers CM, Merks J, Weijerman ME, Lubin JH, Hauptmann M. Confounding of the association between radiation exposure from CT scans and risk of leukemia and brain tumors by cancer susceptibility syndromes. J Radiol Prot 2016; 36: 953-974.

Clement SC, Peeters RP, Ronckers CM, Links TP, Van den Heuvel-Eibrink MM, Nieveen van Dijkum EJ, Van Rijn RR, Van der Pal HJ, Neggers SJ, Kremer LC, van Eck-Smit BL, Van Santen HM. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma - A systematic review. Cancer Treat Rev 2015; 41: 925-34.

Schoot RA, Slater O, Ronckers CM, Zwinderman AH, Balm A, Hartley B, Van den Brekel M, Gupta S, Saeed P, Gajdosova E, Pieters BR, Gaze MN, Mandeville HC, Davila Fajardo R, Ch'ing Chang Y, Strackee SD, Dunaway D, Abela Ch, Mason C, Smeele LE, Chisholm JC, Levitt G, Kremer LC, Grootenhuis MA, Maurice-Stam H, Stiller CA, Hammond P, Caron HN, Merks JHM. Adverse events of local treatment in head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment. Eur J Cancer 2015; 51: 1424-34.

Huijskens SC, van Dijk IWEM, De Jong R, Visser J, Dávila Fajardo R, Ronckers CM, Janssens GORJ, Maduro JH, Rasch CRN, Alderliesten T, Bel A. Quantification of renal and diaphragmatic interfractional motion in pediatric image-guided radiation therapy: A multicenter study. Radiother Oncol 2015; 117: 425-31.

Van Dijk IWEM, Van Os RM, Van de Kamer, JB, Franken NAP, Van der Pal HJH, Koning CCE, Caron HN, Kremer LC*, Ronckers CM*. The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment. J Cancer Surviv 2014; 8: 638-46.

Meulepas JM, Ronckers CM, Smets AM, Nievelstein RA, Jahnen A, Lee C, Kieft M, Laméris JS, Van Herk M, Greuter MJ, Jeukens CR, Van Straten M, Visser O, Van Leeuwen FE, Hauptmann M. Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study. Eur J Epidemiol 2014; 29: 293-301.

Van den Berg MH, Van Dulmen-den Broeder E, Overbeek A, Ronckers CM, Van Dorp W, Kremer LC, Van den Heuvel-Eibrink MM, Huizinga GA, Loonen JJ, Versluys AB, Bresters D, Lambalk CB, Kaspers GJL, Van Leeuwen FE. Fertility studies in female childhood cancer survivors: selecting appropriate comparison groups. Reprod Biomed Online 2014; 29: 352-61.

Van Dijk IWEM, Cardous-Ubbink MC, Van der Pal HJH, Heinen RC, Van Leeuwen FE, Oldenburger F, Vn Os R, Ronckers CM, Schouten - van Meeteren AYN, Caron HN, Koning CCE, Kremer LCM. Dose-effect relationships for adverse events after cranial radiotherapy in long-term childhood cancer survivors. Int J Radiat Oncol Biol Phys 2013; 85: 768-775.

Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, De Vathaire F, Sklar CA, Donaldson SS, Anderson H, Bhatti P, Hammond S, Leisenring WM, Mertens AC, Smith SA, Stovall M, Tucker MA, Weathers RE, Robison LL, Pfeiffer RM. Absolute risk of second primary thyroid cancer for 5-year survivors of a childhood cancer. J Clin Oncol 2013; 31: 119-27.

Overbeek A, Van den Berg MH, Hukkelhoven CWPM, Kremer LC, Van den Heuvel-Eibrink MM, Tissing WJE, Loonen JJ, Versluys AB, Bresters D, Kaspers GJL, Lambalk CB, Van Leeuwen FE, Van Dulmen-den Broeder, and the DCOG LATER/VEVO Study Group. Validity of self-reported data on pregnancies: a comparison with data from a nationwide population-based registry. Hum Reprod 2013; 28:819-27.

Van den Berg MH, Overbeek A, Kremer LC, van den Heuvel-Eibrink MM, Tissing WJE, Loonen JJ, Versluys AB, Bresters D, Kaspers GJL, Lambalk CB, Van Leeuwen FE, Van Dulmen-den Broeder, and the DCOG LATER-VEVO study group. A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges. BMC Cancer 2012; 12: 363.

Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, Parker L, Berrington de Gonzalez A. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours, an historical cohort study. Lancet 2012; 380: 499-505.

Veiga LHS, Bhatti P, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers MS, Leisenring W, Mertens AC, Hammond S, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Friedman DL, Robison LL, Inskip PD. Chemotherapy and the risk of thyroid cancer after a childhood malignancy: an update from the Childhood Cancer Survivor study. Cancer Epidemiology Biomarkers Prevention 2012; 21: 92-101.

Bhatti P, Veiga LHS, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers MS, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD. Radiotherapy for childhood cancer and risk of thyroid cancer in a large cohort study: An update from the Childhood Cancer Survivor Study. Radiat Res 2010; 174: 741-52.

Ronckers CM, Land CE, Miller JS, Stovall M, Lonstein JE, Doody MM. Cancer mortality among women frequently exposed to radiographic exams for spinal disorders. Radiat Res 2010; 174: 83–90.

Ronckers CM, Doody MM, Lonstein JE, Stovall M, Land CE. Multiple diagnostic X-rays, spine deformities and risk of breast cancer. The U.S. Scoliosis Cohort Study. Cancer Epidemiology Biomarkers Prevention 2008; 17: 605-13.

Bluhm EC, Ronckers CM, Hayashi RJ, Neglia JP, Mertens AC, Stovall M, Meadows AT, Mitby PA, Whitton JA, Hammond S, Barker JD, Donaldson SS, Robison LL, Inskip PD. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 2008; 111: 4014-21.

Chodick G, Ronckers CM, Shalev V, Ron E. Excess lifetime mortality due to radiation exposure from pediatric computed tomography examinations. Isr Med Assoc J 2007; 9: 584-7.

Chodik G, Ronckers CM, Ron E, Shalev V. The utilization of pediatric computed tomography in a large Israeli HMO. Pediatric Radiol 2006; 36: 485-90.

Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Mertens AC, Liu Y, Hammond S, Land CE, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip P. Thyroid cancer following pediatric malignancies: A detailed evaluation of radiation dose-response and its modifiers. Radiat Res 2006; 166: 618-28.

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui Y, Meadows AT, Kadan-Lottick NS. Risk of a carcinoma as a subsequent primary neoplasm in survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 2006; 24: 476-83.

Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow R, Sklar CA, Hammond S, Neglia JP, Meadows AT, Robison LL, Inskip PD. Second primary thyroid cancer after a first childhood malignancy: A report from the Childhood Cancer Survivor Study. Lancet 2005; 365: 2014-23.

Ronckers CM, McCarron P, Ron E. Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 2005; 117: 281-88.

Zhang Y, Graubard BI, Klebanoff MA, Ronckers CM, Stanczyk FZ, Longnecker MP, McGlynn KA. Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer 2005; 92: 1787-93.

Ronckers CM, Land CE, Hayes RB, Verduijn PG, van Leeuwen FE. Factors impacting questionnaire response in a Dutch retrospective cohort study. Ann Epidemiol 2004; 14: 66-72.

Ronckers CM, Van Leeuwen FE, Hayes RB, Verduijn PG, Stovall M, Land CE. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology 2002; 13: 552-60.

Ronckers CM, Land CE, Hayes RB, Verduijn PG, Stovall M, Van Leeuwen FE. Late health effects of childhood nasopharyngeal radium irradiation: non-melanoma skin cancers, benign tumors and hormonal disorders. Pediatr Res 2002; 52: 850-8.

Ronckers CM, Land CE, Verduijn PG, Hayes RB, Stovall M, Van Leeuwen FE. Cancer mortality after nasopharyngeal radium irradiation in the Netherlands: a cohort study. J Natl Cancer Inst 2001; 13: 1021-7.

Van den Brandt PA, Dirx MJM, Ronckers CM, Van den Hoogen P, Goldbohm RA. Height. Weight, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control 1997; 8: 39-47.